Published in J Allergy Clin Immunol on April 01, 1979
Effect of artificial food colours on childhood behaviour. Arch Dis Child (1990) 0.97
Tartrazine: a potentially hazardous dye in Canadian drugs. Can Med Assoc J (1982) 0.90
Analgesics, allergy and asthma. Drugs (1986) 0.81
Analgesics, allergy and asthma. Br J Clin Pharmacol (1980) 0.76
Intolerance to acetylsalicylic acid (aspirin) and tartrazine. Evidence of complement activation in a patient following oral challenge with tartrazine. Arch Dermatol Res (1982) 0.75
Sensitivity to tartrazine. Br Med J (Clin Res Ed) (1982) 0.75
Chronic urticaria. Can Fam Physician (1998) 0.75
Chronic urticaria. Br Med J (Clin Res Ed) (1981) 0.75
Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther (1970) 9.54
Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med (1995) 3.91
Urinary prostaglandins. Identification and origin. J Clin Invest (1975) 3.07
Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. N Engl J Med (1985) 2.95
Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol (1982) 2.69
The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med (1965) 2.64
Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med (1975) 2.63
The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat. J Pharmacol Exp Ther (1973) 2.54
Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med (1978) 2.50
Prevalence of acute mountain sickness in the Swiss Alps. BMJ (1990) 2.50
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest (1980) 2.40
Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science (1976) 2.39
Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med (1991) 2.34
Clinical experience over 48 years with pheochromocytoma. Ann Surg (1999) 2.32
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29
Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med (1999) 2.26
Estimated rate of prostacyclin secretion into the circulation of normal man. J Clin Invest (1981) 2.18
Sleep disorders in the elderly. Am J Psychiatry (1988) 2.17
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest (1983) 2.13
Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med (1986) 2.03
Hallucinatory experiences in extreme-altitude climbers. Neuropsychiatry Neuropsychol Behav Neurol (1999) 2.03
Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest (1981) 2.03
Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man. Circulation (1979) 1.88
Ionophores stimulate prostaglandin and thromboxane biosynthesis. Proc Natl Acad Sci U S A (1977) 1.82
Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood (1990) 1.79
Clinical pharmacology of propranolol. Circulation (1975) 1.79
Severe allopurinol hypersensitivity. Association with thiazides and prior renal compromise. Arch Intern Med (1974) 1.76
Successful treatment of acute mountain sickness with dexamethasone. Br Med J (Clin Res Ed) (1987) 1.75
Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. J Clin Invest (1974) 1.74
Pharmacologic and endocrine aspects of carcinoid syndrome. Adv Pharmacol (1967) 1.74
Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team. J Infect Dis (1999) 1.67
Contribution of kinins to endotoxin shock in unanesthetized Rhesus monkeys. Circ Res (1968) 1.66
Simultaneous measurement of cardiac output and its distribution with microspheres in the rat. Cardiovasc Res (1976) 1.66
Normal distribution of cardiac output in the unanesthetized, restrined rhesus monkey. J Appl Physiol (1968) 1.65
Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med (1980) 1.63
Suppression of plasma renin activity by indomethacin in man. Circ Res (1976) 1.62
Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology (1980) 1.60
Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med (1998) 1.60
Simultaneous analysis of dapsone and monoacetyldapsone employing high performance liquid chromatography: a rapid method for determination of acetylator phenotype. Br J Clin Pharmacol (1978) 1.57
Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependence of hyperreninemia on prostaglandin synthesis. Am J Med (1976) 1.55
Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med (1994) 1.54
Time required for complete recovery from chronic propranolol therapy. N Engl J Med (1973) 1.51
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. Eur J Cancer Clin Oncol (1989) 1.48
The role of gastric secretagogues in regulating gastric histamine release in vivo. Gastroenterology (1992) 1.47
Chlorpromazine reversal of the antihypertensive action of guanethidine. Lancet (1971) 1.43
The hemodynamic effects of beta adrenergic blockade on the flow-dependent hepatic clearance of propranolol. J Pharmacol Exp Ther (1973) 1.43
Hypertension and fibromuscular dysplasia of the renal arteries. Surgery (1969) 1.42
Inhibition of monoamine oxidase in man by furazolidone. Clin Pharmacol Ther (1968) 1.40
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol (2011) 1.39
Prostaglandin thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells. Biochim Biophys Acta (1979) 1.39
Persisting myocardial sinusoids of both ventricles as an isolated anomaly: echocardiographic, angiographic, and pathologic anatomical findings. Cardiovasc Intervent Radiol (1986) 1.39
Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. BMJ (1993) 1.39
Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci U S A (1990) 1.38
Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N Engl J Med (1978) 1.37
Biosynthesis of prostaglandin D2. 1. Formation of prostaglandin D2 by human platelets. Prostaglandins (1977) 1.36
Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J Biol Chem (1981) 1.35
Altered hepatic blood flow and drug disposition. Clin Pharmacokinet (1976) 1.34
Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay. Anal Biochem (1999) 1.34
Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther (1978) 1.33
Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med (1979) 1.32
Sustained hypertension after section of the glossopharyngeal nerve. Am J Med (1977) 1.30
[Altitude edema in the Swiss Alps. Observations on the incidence and clinical course in 50 patients 1980-1984]. Schweiz Med Wochenschr (1986) 1.30
Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem (1982) 1.30
Identification of skin as a major site of prostaglandin D2 release following oral administration of niacin in humans. J Invest Dermatol (1992) 1.28
Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol (1981) 1.28
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation (1987) 1.27
Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs. J Pharmacol Exp Ther (1970) 1.26
Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem (1982) 1.26
Effect of indomethacin and aspirin on gastric blood flow and acid secretion. J Pharmacol Exp Ther (1977) 1.25
Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus. N Engl J Med (1981) 1.24
Cigarette smoking and hemostatic function. Am Heart J (1988) 1.23
Formation of a novel dihydroxy acid from arachidonic acid by lipoxygenase-catalyzed double oxygenation in rat mononuclear cells and human leukocytes. J Biol Chem (1982) 1.22
Endogenous prostacyclin biosynthesis and platelet function during selective inhibition of thromboxane synthase in man. J Clin Invest (1983) 1.21
Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg (1981) 1.21
The hemodynamic effects of prostaglandins in the rat. Evidence for important species variation in renovascular responses. Circ Res (1979) 1.20
Preparation and characterization of hydroperoxy-eicosatetraenoic acids (HPETEs). Prostaglandins (1980) 1.20
Operative management of renovascular hypertension. Results after a follow-up of fifteen to twenty-three years. J Vasc Surg (1984) 1.20
Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. J Immunol (1979) 1.20
Kinins: possible mediators of neonatal circulatory changes in man. J Clin Invest (1968) 1.19
The effects of arachidonic acid, prostaglandin E2 and prostaglandin F2alpha on the longitudinal stomach strip of the rat. J Pharmacol Exp Ther (1973) 1.18
Enrichment of rat tissue lipids with fatty acids that are prostaglandin precursors. Biochim Biophys Acta (1975) 1.16
Drug therapy: Psychotropic drug use in the elderly (first of two parts). N Engl J Med (1983) 1.15
Mechanism of increased sodium reabsorption during propranolol administration. Circulation (1971) 1.14
Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med (1999) 1.14
Stereospecific removal of the DR hydrogen atom at the 10-carbon of arachidonic acid in the biosynthesis of leukotriene A4 by human leukocytes. J Biol Chem (1982) 1.14
Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res (1983) 1.14